Evolus Capex To Revenue from 2010 to 2025

EOLS Stock  USD 10.51  0.10  0.94%   
Evolus Capex To Revenue yearly trend continues to be comparatively stable with very little volatility. Capex To Revenue will likely drop to 0.01 in 2025. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.009259
Current Value
0.008796
Quarterly Volatility
0.05714537
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.1 M, Interest Expense of 16.7 M or Selling General Administrative of 190.1 M, as well as many indicators such as Price To Sales Ratio of 4.6, Dividend Yield of 0.0 or Days Sales Outstanding of 74.33. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.
  
Check out the analysis of Evolus Correlation against competitors.

Latest Evolus' Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Evolus Inc over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Evolus' Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

Evolus Capex To Revenue Regression Statistics

Arithmetic Mean0.09
Geometric Mean0.06
Coefficient Of Variation64.44
Mean Deviation0.05
Median0.13
Standard Deviation0.06
Sample Variance0
Range0.1227
R-Value(0.86)
Mean Square Error0.0009
R-Squared0.73
Significance0.000024
Slope(0.01)
Total Sum of Squares0.05

Evolus Capex To Revenue History

2025 0.008796
2024 0.009259
2023 0.008051
2022 0.0198
2021 0.009732
2020 0.0555

About Evolus Financial Statements

Evolus shareholders use historical fundamental indicators, such as Capex To Revenue, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capex To Revenue 0.01  0.01 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.